Momenta Raises $24.1M From Select Investors

Xconomy Boston — 

Momenta Pharmaceuticals, the Cambridge, MA-based developer of generic versions of complex drugs, said today it has received commitments from investors to bet another $24.1 million on the company. The investors are buying 2.8 million shares at $9 a share. The money will be used for manufacturing, clinical trial costs, and potential acquisitions of companies and technologies, the company said.